Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nano-tocotrienols is an oral nano-formulated (liposomal) delivery system of tocotrienols, a subclass of Vitamin E phytonutrients extracted from palm oil. Developed by the Malaysian Palm Oil Board (MPOB) in collaboration with the University of Malaya, this formulation is available in both liquid and powder forms and is designed to significantly enhance the bioavailability and absorption of tocotrienols compared to standard formulations. Tocotrienols possess potent antioxidant, anti-inflammatory, and lipid-lowering properties. Nano-tocotrienols are being evaluated in clinical trials to determine their long-term safety, tolerability, and potential therapeutic benefits as a health supplement in healthy individuals and patients with Type 2 diabetes mellitus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nano-tocotrienols.